Pearls and Pitfalls in Interpretation of 68Ga-DOTATOC PET Imaging
Overview
Affiliations
DOTA-D-Phe-Tyr-octreotide labeled with Ga (Ga-DOTATOC) is the commonly used PET tracer for imaging meningioma because of its high affinity to somatostatin receptor subtype 2 (SSTR2) and an established imaging modality for planning radiation and radionuclide therapy. However, SSTR2 is not an exclusive marker for meningioma, and not all meningiomas express high levels of SSTR2. The SSTR2 expression has been reported in other intracranial tumors, for example, glioma, pituitary adenoma, medullablastoma, primitive neuroectodermal tumors, and hemangioblastoma leading to a significant risk of misinterpretation of PET/CT findings. We present 2 cases with similar Ga-DOTATOC uptakes in 2 distinct etiologies, for example, cerebral lymphoma and meningioma.
Albert N, Preusser M, Traub-Weidinger T, Tolboom N, Law I, Palmer J Eur J Nucl Med Mol Imaging. 2024; 51(12):3662-3679.
PMID: 38898354 PMC: 11445317. DOI: 10.1007/s00259-024-06783-x.
Calabria F, Bagnato A, Guadagnino G, Toteda M, Lanzillotta A, Cardei S Oncol Res. 2023; 31(2):117-124.
PMID: 37304242 PMC: 10207995. DOI: 10.32604/or.2023.027705.
Advances in PET imaging for meningioma patients.
Galldiks N, Albert N, Wollring M, Werner J, Lohmann P, Villanueva-Meyer J Neurooncol Adv. 2023; 5(Suppl 1):i84-i93.
PMID: 37287577 PMC: 10243856. DOI: 10.1093/noajnl/vdac113.
Bellini P, Dondi F, Albano D, Bertagna F Indian J Nucl Med. 2023; 37(3):259-260.
PMID: 36686292 PMC: 9855231. DOI: 10.4103/ijnm.ijnm_197_21.
Molecular imaging in oncology: Common PET/CT radiopharmaceuticals and applications.
Franquet E, Park H Eur J Radiol Open. 2022; 9:100455.
PMID: 36439301 PMC: 9691399. DOI: 10.1016/j.ejro.2022.100455.